Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Case 22% Improvement Relative Risk c19hcq.org Datta et al. HCQ for COVID-19 PrEP Is pre-exposure prophylaxis with HCQ beneficial for COVID-19? Retrospective 281 patients in India Fewer cases with HCQ (not stat. sig., p=0.47) Datta et al., J. Vaccines & Vaccination, S6:1000002 Favors HCQ Favors control
No Role of HCQ in COVID-19 Prophylaxis: A Survey amongst Indian Doctors
Datta et al., Journal of Vaccines & Vaccination, S6:1000002
Datta et al., No Role of HCQ in COVID-19 Prophylaxis: A Survey amongst Indian Doctors, Journal of Vaccines & Vaccination, S6:1000002
Nov 2020   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Survey of Indian doctors not finding a significant effect of HCQ prophylaxis.
Although the 22% fewer cases is not statistically significant, it is consistent with the significant 30% fewer cases [22‑38%] from meta analysis of the 73 cases results to date.
risk of case, 22.1% lower, RR 0.78, p = 0.47, treatment 16 of 146 (11.0%), control 19 of 135 (14.1%), NNT 32.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Datta et al., 6 Nov 2020, retrospective, India, peer-reviewed, 7 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: tio cina n ac Journal o OPEN ne acci s & V fV ISSN: 2157-7560 Journal of Vaccines & Vaccination ACCESS Freely available online Short Communication No Role of HCQ in COVID-19 Prophylaxis: A Survey amongst Indian Doctors Debasis Datta 1, Samit Ghosal2*, Binayak Sinha3, Sujata Datta4,Twisha Chakraborty5, Kalyan Kumar Gangopadhyay6, Arup Ratan Dutta7 Department of Gastroenterology, Fortis Hospitals, Kolkata, India; 2Department of Endocrinology, Nightingale Hospital, Kolkata, India;3Department of Diabetes and Endocrinology, AMRI Hospitals, Kolkata, India;4Department of Gynecology, Peerless Hospitals, Kolkata, India;5 Department of Gastroenterology, Fortis Hospitals Kolkata, India;6 Department of Endocrinology, Peerless Hospitals, Kolkata, India;7Department of Nephrology, Fortis Hospitals, Kolkata, India 1 ABSTRACT The COVID-19 pandemic is being tackled on two fronts-prevention and treatment. In addition to behavioural strategies and vaccines (eagerly awaited), pharmacotherapy is also being employed in certain regions as a preventive strategy. In India, hydroxychloroquine (HCQ), ivermectin, a variety of vitamin supplements are being used, with HCQ being the most popular among healthcare professionals. In addition to the evidence-based recommendations, it is important to ascertain the situation on the ground. We conducted a multicentric survey among physicians from a wide range of specialities to ascertain the usage on HCQ and its effects of COVID-19 prevention. We did not find any significant impact of HCQ on the prevention of COVID-19 (p=0.54) independent of the duration of its usage. This pilot project has the potential to act as a backbone for a larger study exploring the impact of pharmacological intervention on COVID-19 prevention. Keywords: COVID-19; Survey; Physicians; HCQ
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit